TipRanks
Xspray Pharma AB (DE:6XP)
FRANKFURT:6XP
Germany Market

Xspray Pharma AB (6XP) Cash flow

2 Followers

Xspray Pharma AB Cash Flow

DE:6XP's free cash flow for Q2 2026 was kr-47.25M. For the 2026 fiscal year, DE:6XP's free cash flow was decreased by kr42.16M and operating cash flow was kr-36.95M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -193.16Mkr -222.37Mkr -203.28Mkr -110.18Mkr -51.61M
Investing Cash Flow
kr -29.19Mkr -42.14Mkr -65.88Mkr -135.34Mkr -105.82M
Financing Cash Flow
kr 168.29Mkr 306.11Mkr 315.59Mkr 93.81Mkr 103.71M
End Cash Position
kr 153.75Mkr 208.24Mkr 166.30Mkr 120.17Mkr 271.88M
Free Cash Flow
kr -222.35Mkr -264.51Mkr -257.38Mkr -238.47Mkr -147.57M
Currency in SEK

Xspray Pharma AB Cash Flow